Dr. FAEZEH MAGHSOOD | Infectious disease | Best Researcher Award

Faezeh Maghsood (b. January 5, 1990, Iran)  is a highly skilled immunologist specializing in vaccine development, monoclonal antibodies, and immunotherapy for cancer and infectious diseases.  With a B.Sc., M.Sc., and Ph.D. in Medical Immunology from Tehran University of Medical Sciences (TUMS), she has consistently ranked at the top throughout her academic journey.  She currently works as a Research Associate at TUMS and has previously held positions at the Pasteur Institute of Iran and renowned clinical labs. 🧪 Her Ph.D. work focused on SARS-CoV-2 monoclonal antibody production, earning her multiple prestigious awards.  She has contributed to peer-reviewed journals and actively participates in global scientific events, including immunology congresses in Japan  and Iran. Faezeh is passionate about cutting-edge biomedical research, particularly tumor immunology and stem cells, and continues to push the boundaries in translational medicine.

Profile

Scholar

🎓 Education

Faezeh earned her B.Sc. in Medical Laboratory Sciences (2008–2012) from TUMS with a GPA of 18.33/20, showcasing her early interest in clinical diagnostics. She pursued her M.Sc. in Medical Immunology (2012–2016) at the same university, achieving an impressive GPA of 19.32/20, and researched probiotics’ effects on MMPs and immune markers . Her Ph.D. in Medical Immunology (2018–2023) was also from TUMS, with a GPA of 18.61/20, culminating in a thesis on the structural and functional characterization of neutralizing mouse monoclonal antibodies against SARS-CoV-2 under the supervision of Prof. Fazel Shokri and Dr. Amiri . Her academic journey reflects a strong foundation in both theoretical and applied aspects of immunological sciences, bolstered by exceptional talent recognition and consistent academic excellence .

👩‍🏫 Experience

Faezeh currently serves as a Research Associate at Tehran University of Medical Sciences (2024–Present), where she contributes to cutting-edge immunology research . Previously, she worked as a Research Assistant and Lab Manager (2015–2018) at the Pasteur Institute of Iran’s Biochemistry Department in the Stem Cell Lab . Her clinical background includes valuable roles in diagnostic laboratories at Shariati Hospital and Imam Khomeini Hospital during 2011–2012 . This diverse experience combines academic research, lab management, and hands-on clinical diagnostics, equipping her with a comprehensive skillset in experimental design, immunoassays, and lab operations . She actively participates in international training programs, enhancing her knowledge in genome editing, CRISPR/Cas9, RNA-seq, and R programming .

🏆 Awards & Honors

Faezeh has received several notable accolades, including 3rd place in the M8 Alliance Best PhD Thesis Prize (2024)  and selection as Best PhD Thesis at TUMS . She was ranked 1st nationally in Iran’s 2018 Ph.D. entrance exam in medical sciences . During her M.Sc. studies, she was acknowledged as an exceptionally talented student at TUMS’s Faculty of Allied Medicine (2012) and was the top student throughout her undergraduate years (2008–2012) . These achievements highlight her unwavering dedication, academic excellence, and research leadership . Faezeh’s accomplishments reflect a persistent pursuit of innovation and a strong commitment to contributing meaningfully to global scientific advancement, particularly in the fields of immunotherapy and biomedical diagnostics .

🔬 Research Focus

Faezeh’s research is deeply rooted in medical immunology, with core interests in vaccine development, monoclonal antibody production, and immunotherapy for cancer and infectious diseases . Her Ph.D. project involved the creation and detailed analysis of neutralizing monoclonal antibodies targeting SARS-CoV-2, highlighting her expertise in virology and structural immunology . She is also passionate about tumor immunology, exploring immune mechanisms in oncology, and advancing stem cell-based therapies . Faezeh is dedicated to bridging basic science with clinical application, using advanced methods like flow cytometry, CRISPR/Cas9 editing, RNA-Seq, and bioinformatics for translational immunological research . Her interdisciplinary focus aims to address global health challenges through innovation, collaboration, and precision medicine.

 Conclusion

Dr. Faezeh Maghsood is an exceptionally promising early-career researcher in medical immunology with a strong academic foundation, robust research outputs, and international exposure. Her work on monoclonal antibodies and SARS-CoV-2 is not only timely but also highly significant in the global health landscape. While she is still in the early stages of building a fully independent research portfolio, her trajectory, productivity, and recognition make her a highly suitable and worthy candidate for a Best Researcher Award, particularly in the early-career or emerging investigator category.

Publication

1. Title: Hypoxia pre-conditioned embryonic mesenchymal stem cell secretome reduces IL-10 production by peripheral blood mononuclear cells
   Year: 2017
   Authors: M Lotfinia, S Lak, NM Ghahhari, B Johari, F Maghsood, S Parsania, …
   Citation: 45

 

1. Title: Anti-proliferative and Anti-metastatic Potential of High Molecular Weight Secretory Molecules from Probiotic Lactobacillus Reuteri Cell-Free Supernatant Against …
   Year: 2020
   Authors: F Maghsood, B Johari, M Rohani, H Madanchi, Z Saltanatpour, M Kadivar
   Citation: 44

 

1. Title: Dual effects of cell free supernatants from Lactobacillus acidophilus and Lactobacillus rhamnosus GG in regulation of MMP-9 by up-regulating TIMP-1 and down-regulating CD147 in …
   Year: 2017
   Authors: F Maghsood, A Mirshafiey, MM Farahani, MH Modarressi, P Jafari, …
   Citation: 43

 

1. Title: Myc decoy oligodeoxynucleotide inhibits growth and modulates differentiation of mouse embryonic stem cells as a model of cancer stem cells
   Year: 2017
   Authors: B Johari, M Ebrahimi-Rad, F Maghsood, M Lotfinia, Z Saltanatpouri, …
   Citation: 23

 

1. Title: SARS‐CoV‐2 nucleocapsid: Biological functions and implication for disease diagnosis and vaccine design
   Year: 2023
   Authors: F Maghsood, A Ghorbani, H Yadegari, F Golsaz‐Shirazi, MM Amiri, …
   Citation: 17

 

1. Title: Diagnostic performance of a novel antigen-capture ELISA for the detection of SARS-CoV-2
   Year: 2023
   Authors: H Yadegari, M Mohammadi, F Maghsood, A Ghorbani, T Bahadori, …
   Citation: 16

 

1. Title: Does prior immunization with measles, mumps, and rubella vaccines contribute to the antibody response to COVID-19 antigens?
   Year: 2021
   Authors: D Hassani, MM Amiri, F Maghsood, V Salimi, GA Kardar, O Barati, …
   Citation: 16

 

1. Title: Epitope mapping of severe acute respiratory syndrome coronavirus 2 neutralizing receptor binding domain-specific monoclonal antibodies
   Year: 2022
   Authors: F Maghsood, MM Amiri, AH Zarnani, V Salimi, GA Kardar, J Khoshnoodi, …
   Citation: 14

 

1. Title: The effect of Trimetazidine and Diazoxide on immunomodulatory activity of human embryonic stem cell-derived mesenchymal stem cell secretome
   Year: 2017
   Authors: S Jahandideh, F Maghsood, NM Ghahhari, M Lotfinia, M Mohammadi, …
   Citation: 14

 

1. Title: Epitope mapping of neutralising anti‐SARS‐CoV‐2 monoclonal antibodies: implications for immunotherapy and vaccine design
   Year: 2022
   Authors: S Ghotloo, F Maghsood, F Golsaz‐Shirazi, MM Amiri, C Moog, F Shokri
   Citation: 12

 

1. Title: Identification of immunodominant epitopes on nucleocapsid and spike proteins of the SARS-CoV-2 in Iranian COVID-19 patients
   Year: 2022
   Authors: F Maghsood, MR Shokri, M Jeddi-Tehrani, M Torabi Rahvar, A Ghaderi, …
   Citation: 11

 

1. Title: Inhibition of transcription factor T‐cell factor 3 (TCF3) using the oligodeoxynucleotide strategy increases embryonic stem cell stemness: Possible application in regenerative …
   Year: 2019
   Authors: B Johari, Z Asadi, E Rismani, F Maghsood, Z Sheikh Rezaei, S Farahani, …
   Citation: 11

 

1. Title: Anti-inflammatory property of β-D-mannuronic acid (M2000) on expression and activity of matrix metalloproteinase-2 and-9 through CD147 molecule in phorbol myristate acetate …
   Year: 2017
   Authors: MM Farahani, E Motevaseli, F Maghsood, M Heidari-Kharaji, A Mirshafiey
   Citation: 11